Day: November 22, 2022

Timbercreek Financial Declares November 2022 Dividend

Timbercreek Financial Declares November 2022 Dividend

TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on December 15, 2022 to holders of Common Shares of record on November 30, 2022. The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees. Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent of the average market price...

Continue reading

Amedisys Names Scott Ginn Acting Chief Operating Officer

Amedisys Names Scott Ginn Acting Chief Operating Officer

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately. “I am delighted to have Scott Ginn serving as a trusted partner in this critical role on our leadership team,” stated Paul Kusserow, Chairman and CEO of Amedisys. “Scott is well respected within Amedisys and the industry and this appointment will generate enormous enthusiasm. I am fully confident that his intimate knowledge of both Amedisys’ finance and operations will enable us to deliver strong results and continue to provide the industry’s best care to our people and our patients.” Ginn has led financial teams at Amedisys since 2007, serving...

Continue reading

Record Date is set for the Distribution of 25% Interest in Brookfield’s Asset Management Business

Record Date is set for the Distribution of 25% Interest in Brookfield’s Asset Management Business

All material approvals have been received and the Manager shares are expected to be distributed on December 9, 2022 BROOKFIELD, NEWS, Nov. 22, 2022 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (NYSE: BAM, TSX: BAM.A) (“Brookfield”) and Brookfield Asset Management Ltd. (the “Manager”) today jointly announced a distribution record date of December 2, 2022 for the previously announced transaction for the public listing and distribution of a 25% interest in Brookfield’s asset management business, through the Manager, by way of a plan of arrangement (“Arrangement”). The transaction will result in the division of Brookfield into two publicly traded companies – the Corporation (Brookfield Asset Management Inc. will be renamed “Brookfield Corporation”) and the Manager (“Brookfield Asset Management Ltd.”). Brookfield has now received...

Continue reading

uniQure announces FDA approval of first gene therapy for adults with hemophilia B

uniQure announces FDA approval of first gene therapy for adults with hemophilia B

Lexington Facility uniQure’s commercial manufacturing facility in Lexington, MA Manufacturing State-of-the-art global commercial manufacturing at uniQure ~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels ~ ~ uniQure conducted the multi-year clinical development program and will now leverage its leading gene therapy manufacturing capabilities to supply CSL for commercialization ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 22, 2022 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced that its partner, global biotechnology leader CSL (ASX: CSL), has...

Continue reading

Jushi Holdings Inc. Files a Copy of its S-1 Registration Statement in Canada

Jushi Holdings Inc. Files a Copy of its S-1 Registration Statement in Canada

BOCA RATON, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that, further to a review by the Ontario Securities Commission (the “OSC”) of the Company’s continuous disclosure and a subsequent request from OSC staff in connection therewith, the Company has filed its registration statement on Form S-1 (the “Registration Statement”), made effective with the United States Securities and Exchange Commission on August 12, 2022, on SEDAR in accordance with OSC Staff Notice 57-711 (Revised) Refilings and Corrections of Errors (“Notice 51-711”) in order to make the corrective disclosure described in this press release. Prior to the Registration Statement becoming effective, the Company prepared its financial...

Continue reading

Freddie Mac Issues Monthly Volume Summary for October 2022

Freddie Mac Issues Monthly Volume Summary for October 2022

MCLEAN, Va., Nov. 22, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for October 2022, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac, and Freddie Mac’s blog FreddieMac.com/blog. MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@freddiemac.com INVESTOR...

Continue reading

FRIEDMAN INDUSTRIES, INCORPORATED PROVIDES SINTON FACILITY UPDATE AND UPDATE ON FORM 10-Q FILING

FRIEDMAN INDUSTRIES, INCORPORATED PROVIDES SINTON FACILITY UPDATE AND UPDATE ON FORM 10-Q FILING

SINTON UPDATE LONGVIEW, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) — On October 25, 2022, the Company started shipping material to customers from its newly constructed coil processing facility in Sinton, Texas. The facility consists of a 70,000 square foot building located on 26.5 acres leased from Steel Dynamics, Inc. at their new flat roll steel mill campus. Material is processed on a new stretcher leveler cut-to-length line that is capable of handling steel coils up to 1” thick, widths up to 96” wide and yields exceeding 100,000 psi. The equipment commissioning process has gone smoothly so far and the customer response has been very positive. The quality of the initial material processed has been outstanding giving the Company great confidence marketing the facility’s offerings to customers. The facility is currently staffed to operate...

Continue reading

Qomolangma Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants

Qomolangma Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants

New York, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) — Qomolangma Acquisition Corp. (Nasdaq: QOMOU) (the “Company”) announced that, commencing Friday, November 25, 2022, holders of the units sold in the Company’s initial public offering of 5,273,000 units (the “Units”) may commence separate trading of the underlying component securities. Each Unit consists of one share of common stock of the Company, par value $0.0001 (the “Common Stock”), one redeemable warrant, which is exercisable for one share of Common Stock at a price of $11.50 per share, and one right to receive one-tenth (1/10th) of one share of Common Stock upon the consummation of the Company’s initial business combination. Those Units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “QOMOU.” The shares of Common Stock, rights and...

Continue reading

HP Inc. Reports Fiscal 2022 Full Year and Fourth Quarter Results; Announces Dividend Increase and Future Ready Transformation

HP Inc. Reports Fiscal 2022 Full Year and Fourth Quarter Results; Announces Dividend Increase and Future Ready Transformation

PALO ALTO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) — HP (NYSE: HPQ) Fiscal 2022 GAAP diluted net earnings per share (“EPS”) of $3.05, below the previously provided outlook of $3.46 to $3.56 per share Fiscal 2022 non-GAAP diluted net EPS of $4.08, within the previously provided outlook of $4.02 to $4.12 per share Fiscal 2022 net revenue of $63.0 billion, down 0.8% from the prior-year period                      Fiscal 2022 net cash provided by operating activities of $4.5 billion, free cash flow of $3.9 billion Fiscal 2022 returned $5.3 billion to shareholders in the form of share repurchases and dividends Fourth quarter GAAP diluted net EPS was negligible, below the previously provided outlook of $0.44 to $0.54 per share, due to one-time non-cash tax adjustments Fourth quarter non-GAAP diluted net EPS of $0.85, within...

Continue reading

Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update

JERUSALEM, Nov. 22, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported third quarter 2022 financial results and provided a corporate update. “Alpha Tau remained active in the third quarter, as we continued preparations for our upcoming U.S. pivotal study in recurrent cutaneous squamous cell carcinoma and laid the groundwork for exploration of our Alpha DaRT oncology treatment platform across a broad set of applications,” said Alpha Tau CEO Uzi Sofer. “At the same time, we have remained highly visible through a series of scientific publications and presentations to discuss our Alpha DaRT treatment. In anticipation of pivotal study data and a potential U.S....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.